Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001583742-20-000002

CEO & President acquired 158,017,321 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hakim Nasrat A CEO & President 2020-08-24 Conversion +158,017,321 167,114,882 D
Derivatives
Hakim Nasrat A CEO & President 2020-08-24 Conversion · Series J Convertible Preferred Shares −24.03 0 D
Loading xslF345X03/primary_doc.xml…